Chemical activators of Olr734 can engage the protein through a cascade of intracellular signaling events primarily involving the elevation of cyclic adenosine monophosphate (cAMP) levels. Forskolin, a diterpene, directly stimulates adenylate cyclase, the enzyme responsible for converting adenosine triphosphate (ATP) to cAMP. The rise in cAMP activates protein kinase A (PKA), which can phosphorylate Olr734, leading to its activation. Similarly, Isoproterenol, a synthetic catecholamine, targets beta-adrenergic receptors, triggering Gs protein coupling and subsequent adenylate cyclase activation. This process also culminates in PKA-mediated phosphorylation of Olr734. Natural catecholamines like Epinephrine engage with alpha and beta-adrenergic receptors to produce similar effects, while Histamine binds H2 receptors to activate adenylate cyclase through Gs proteins.
Serotonin, through its action on specific 5-HT receptors, Dopamine via D1-like receptors, and Adenosine engaging A2 receptors, all promote adenylate cyclase activity, thus enhancing cAMP and activating PKA, which in turn can phosphorylate and activate Olr734. Prostaglandin E2, through interaction with EP2/EP4 receptors, and Glucagon, via its own receptor, employ similar mechanisms to activate adenylate cyclase, increasing cAMP and activating PKA, which may then activate Olr734. Furthermore, Caffeine and IBMX, through inhibition of phosphodiesterases, prevent the breakdown of cAMP, sustaining PKA activation. PKA, thus maintained in an active state, is poised to activate Olr734 through phosphorylation. Lastly, BAY 60-6583, which selectively activates adenosine A2B receptors, results in enhanced adenylate cyclase activity and elevated cAMP levels. This, like the other chemicals, leads to PKA activation, which can phosphorylate and activate Olr734, illustrating a network of pathways converging on the activation of Olr734.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Binds to and activates beta-adrenergic receptors, which are coupled to Gs proteins that activate adenylate cyclase. This increases cAMP levels, activating PKA, which can result in the phosphorylation and activation of Olr734. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Interacts with both alpha and beta-adrenergic receptors to increase adenylate cyclase activity, thus raising intracellular cAMP levels, leading to PKA activation and potential phosphorylation and activation of Olr734. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to H2 receptors which are positively coupled to adenylate cyclase via Gs proteins, increasing cAMP levels and thereby activating PKA. Activated PKA can phosphorylate and activate Olr734. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Acts on 5-HT receptors linked to adenylate cyclase activation, leading to an increase in cAMP, which activates PKA. PKA activation can lead to phosphorylation and activation of Olr734. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Binds to D1-like receptors, which are coupled to adenylate cyclase, leading to increased cAMP levels and subsequent activation of PKA. PKA can phosphorylate and activate Olr734. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activates A2 receptors which are coupled to adenylate cyclase, resulting in increased cAMP and activation of PKA. PKA may phosphorylate and activate Olr734. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Engages EP2/EP4 receptors leading to adenylate cyclase activation. The increase in cAMP activates PKA, which could phosphorylate and activate Olr734. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Inhibits phosphodiesterases which leads to an increase in cAMP levels by preventing its degradation, thereby sustaining the activation of PKA, which can phosphorylate and activate Olr734. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases leading to increased cAMP levels and sustained activation of PKA, which can then phosphorylate and activate Olr734. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
Selectively activates adenosine A2B receptors, contributing to an increase in adenylate cyclase activity and cAMP levels, which leads to activation of PKA that can phosphorylate and activate Olr734. | ||||||